BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22624050)

  • 1. Transgenic mice for a tamoxifen-induced, conditional expression of the Cre recombinase in osteoclasts.
    Sanchez-Fernandez MA; Sbacchi S; Correa-Tapia M; Naumann R; Klemm J; Chambon P; Al-Robaiy S; Blessing M; Hoflack B
    PLoS One; 2012; 7(5):e37592. PubMed ID: 22624050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice that express Cre recombinase in osteoclasts.
    Chiu WS; McManus JF; Notini AJ; Cassady AI; Zajac JD; Davey RA
    Genesis; 2004 Jul; 39(3):178-85. PubMed ID: 15282744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
    Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
    Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
    Xu J; Yao G; Ru Y; Xie S
    Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
    Zhao J; Nassar MA; Gavazzi I; Wood JN
    Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.
    Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H
    Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.
    Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP
    Curr Biol; 1998 Dec; 8(24):1323-6. PubMed ID: 9843687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPC-Cre-ERT2 transgenic mouse for temporal gene deletion in alveolar epithelial cells.
    Gui YS; Wang L; Tian X; Feng R; Ma A; Cai B; Zhang H; Xu KF
    PLoS One; 2012; 7(9):e46076. PubMed ID: 23049940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
    Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
    Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of NSE-MerCreMer transgenic mice with tamoxifen inducible Cre activity in neurons.
    Kam MK; Lee KY; Tam PK; Lui VC
    PLoS One; 2012; 7(5):e35799. PubMed ID: 22586451
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang X; Lauth A; Wan TC; Lough JW; Auchampach JA
    Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33106234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating conditional knockout mice.
    Friedel RH; Wurst W; Wefers B; Kühn R
    Methods Mol Biol; 2011; 693():205-31. PubMed ID: 21080282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele.
    Korecki AJ; Hickmott JW; Lam SL; Dreolini L; Mathelier A; Baker O; Kuehne C; Bonaguro RJ; Smith J; Tan CV; Zhou M; Goldowitz D; Deussing JM; Stewart AF; Wasserman WW; Holt RA; Simpson EM
    Genetics; 2019 Apr; 211(4):1155-1177. PubMed ID: 30765420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
    Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
    Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
    Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
    Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.